Clinical Trial Update: Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is evaluating the combination of ADI-PEG20 with carboplatin and cabazitaxel for aggressive variant prostate cancer and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ADI-PEG20 (pegylated arginine deiminase)
• CARBOPLATIN (Carboplatin)
• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING